Correlation of Clinical Rating Scale for Tremor with Global Assessment
Objective: Objective: The objective was to determine the association of the Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (CRST) scores with the CRST global assessment. Background:…Altered activity of lysosomal hydrolases in monocyte-derived macrophages as potential biomarker for differential diagnosis of multiple system atrophy
Objective: The aim was to assess the possibility of differentiating synucleinopathies (Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) by lysosomal…Longitudinal Analysis of fragile X-associated tremor/ataxia syndrome Progression: A One-Year Follow-Up of 24 Patients
Objective: Determine the rate of progression of motor signs in fragile X-associated tremor/ataxia syndrome (FXTAS) over a one-year follow-up. Background: Limited information exists regarding the…Acute dystonic dyskinesias in a patient used fluvoxamine. Case report
Objective: To represent a case of acute dystonic dyskinesias after fluvoxamine use by the patient with obsessive thoughts and movements. Background: In psychiatric clinical practice,…Association between Dipeptidyl Peptidase-4 Inhibitor Usage and Mortality in Parkinson’s Disease: a nation-wide study
Objective: To investigate whether usage of dipeptidyl peptidase IV inhibitors (DPP4i) is associated decreased mortality in Parkinson’s disease (PD). Background: Type 2 diabetes mellitus (T2DM)…Validation of the Kazakh Version of the Movement Disorder Society-Unified Dyskinesia Rating Scale.
Objective: This study aimed to validate the Kazakh version of the Movement Disorder Society-Unified Dyskinesia Rating Scale Background: The Unified Dyskinesia Rating Scale (UDysRS) has…Movement Disorder Society Unified Parkinson’s Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States
Objective: This study aims to validate the two-domain structure of MDS-UPDRS Part III items in both medication states, exploring the discriminative ability of the tremor…Clinical and neuroimaging factors associated with survival in Multiple System Atrophy
Objective: To assess clinical and neuroimaging factors associated with survival in a cohort of patients with a final clinical diagnosis of Multiple System Atrophy (MSA)…Visuospatial-Visuoconstructive Alterations and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology in patients with IPDWD correlates with visuospatial and/or visuoconstructive alterations Background: Visuospatial functioning and/or visuoconstructive skills are a cognitive…Predicting the Risk of Parkinson’s Disease by Body Composition and Metabolic Diseases in Gender and Age Dependent Manners
Objective: Objective: This study intends to analyze the impact of body composition and metabolic diseases on the risk of Parkinson's disease (PD) using large-scale longitudinal…
- « Previous Page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- …
- 1554
- Next Page »